Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Genemarkers Sponsors Rare Disease Challenge

Published: Thursday, May 02, 2013
Last Updated: Thursday, May 02, 2013
Bookmark and Share
Genemarkers to sponsor the Rare Disease Science Challenge: Be HEARD (Helping Empower and Accelerate Research Discoveries) and work with Lori Silveira at National Jewish Health on her research project.

Genemarkers will be providing Genomics Expression Analysis for Silveira’s research on Chronic Beryllium Disease (CBD). Silveira was selected out of 77 applicants covering 67 types of rare disease.

"We are thrilled to be part of the Rare Disease Challenge and to have the opportunity to assist Lori Silveira,” says Dr. Anna Langerveld, president and CEO of Genemarkers. “We are proud that our team of experienced genomics scientists can assist in advancing this research.”

Genemarkers joins 19 other companies as service donors for the competition, hosted by Assay Depot and Rare Genomics Institute. Rare Genomic Institute’s expert panel and a Genemarkers technical expert selected winners for the service donation. The total value of all services reached $500,000, which will go towards helping accelerate rare disease research. To view all service winners and company donations, please visit http://challenge.assaydepot.com/rare-disease-awards.

The competition also features a $10,000 prize with the winner being chosen by Facebook voting. The community can participate by voting for their favorite research proposals on Facebook at http://www.facebook.com/raregenomics.

Genemarkers will work with Lori Silveira over the next few months and push Chronic Beryllium Disease (CBD) research to a new level.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!